Squarepoint’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
Squarepoint's GMAB Position: Q3 2026 in Review
Squarepoint sold out of Genmab (GMAB) in Q3 2026, closing a stake of 7,421 shares — an estimated $204K sold.
Squarepoint first reported a position in GMAB in Q4 2020 and held it in 15 quarters. The position peaked at $2.45M in Q4 2024. 204 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Squarepoint reported no remaining Genmab position as of Q3 2026 after selling out during the quarter.
- Squarepoint sold 7,421 Genmab shares in Q3 2026, an estimated $204K.
- Squarepoint first reported a position in Genmab in Q4 2020 and held it in 15 quarters.
- Squarepoint's Genmab position peaked at $2.45M in Q4 2024.
- 204 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.